Fine Mapping and Function of Genes for Type 1 Diabetes (DP3)

The summary for the Fine Mapping and Function of Genes for Type 1 Diabetes (DP3) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Fine Mapping and Function of Genes for Type 1 Diabetes (DP3): -Purpose. This FOA issued by the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, solicits Research Project Grant (DP3) applications from institutions/organizations for research on projects to carry out fine mapping studies as well as to investigate the function of the genes involved in type 1 diabetes. To date, genome-wide association studies (GWAS) of type 1 diabetes have yielded promising results. However, follow-up studies are needed to eliminate false positives, extend the findings to diverse populations (diverse in terms of ethnicity or environmental exposures) and narrow the association interval. The purpose of this funding opportunity is to provide support for replication and fine-mapping studies of genetic regions putatively associated with type 1 diabetes. In addition, studies of the function of the genes identified and the mechanisms by which they may alter risk are needed. This initiative will also solicit proposals on the application of new technologies to genetics of type 1 diabetes and the study of the role of these genes in the etiopathogenesis of type 1 DM. The identification of these genes and function will help define etiological pathways and leads for new therapeutic targets. -Mechanism of Support. This FOA will utilize the DP3 grant mechanism. -Funds Available and Anticipated Number of Awards. The total funding for this five year program this year is $20 million for the five year period. It is anticipated that 4-10 awards will be made.

Federal Grant Title:	Fine Mapping and Function of Genes for Type 1 Diabetes (DP3)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DK-08-006
Type of Funding:	Grant
CFDA Numbers:	93.847
CFDA Descriptions:	Diabetes, Endocrinology and Metabolism Research
Current Application Deadline:	Mar 30, 2009
Original Application Deadline:	Mar 30, 2009
Posted Date:	Oct 16, 2008
Creation Date:	Oct 16, 2008
Archive Date:	Apr 30, 2009
Total Program Funding:	$20,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Tribally Controlled Colleges and Universities (TCCUs) .
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial...; • Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial...; • Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortiu...; • Diabetes Research Centers (P30 Clinical Trial Optional); • Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogen...; • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes; • Molecular Therapy Core Centers; • Pilot and Feasibility Program in Human Islet Biology
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...